Read article—Research by Jack Wennberg, the late founder and director emeritus of The Dartmouth Institute, is cited in an article about health care affordability. Wennberg’s work found that physician and hospital practice patterns vary widely across the country, with local supply rising to meet the demands of local practitioners.
In the News
Docs Land Nearly $400 Million in First Year of Controversial Medicare Billing Code—MedScape
Read article—Andrew Schuman, a clinical assistant professor of pediatrics, is quoted in an article about compensation for medical professionals. “Primary care is the base of a pyramid where we generate a lot of services and generate a lot of revenue for institutions and for specialists,” Schuman said. “It’s an important code because it emphasizes the importance of providers in coordinating care.”
Free 10-Minute Online Programs Aimed at Overcoming Depression Led to Real Improvements – New Research—The Conversation
Read article—An opinion piece by Benjamin Kaveladze, a postdoctoral fellow at the Center for Technology and Behavioral Health, about his new paper reporting that even small interventions can lead to measurable improvements in depressive symptoms. “Our study is the first to show that single-session interventions can lead to monthlong reductions in depression in adults,” Kaveladze writes.
The False Promise of a ‘No Sugar’ Diet—Vox
Read article—Quotes Amer Al-Nimr, a professor of pediatrics and medicine, in an article offering a nuanced look at the health profile of sugar. “We don’t want people getting the message that food is bad or that food is a source of concern or a source of anxiety,” Al-Nimr said.
When Should AI Chatbots Call the Cops?—POLITICO
Read article—Nicholas Jacobson, an associate professor of biomedical data and psychiatry, is quoted in an article about whether AI companies should be obligated to contact police if users display the potential for violent behavior. The story details the clinical safeguards of Therabot, an AI therapy platform developed in Jacobson’s lab. “What I think would be a better outcome for everyone involved is if there were greater levels of clinical oversight,” Jacobson said. “That would (involve) escalation pathways that are more appropriate, that would end up managing risks rather than trying to hand them off to external parties.”
Using AI as a Therapist? Why Professionals Say You Should Think Again—CNET
Read article—Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, is quoted in an article about therapy chatbots that includes details on Therabot, a platform developed in his lab.
Effort to ‘Modernize’ Eye Care Shouldn’t Come at the Expense of Patient Safety—New Hampshire Bulletin
Read article—Michael E. Zegans, a professor of surgery and of microbiology and immunology, writes an opinion piece about a bill that would allow optometrists, who are not medical doctors or trained surgeons, to perform eye surgeries in New Hampshire. “Surgery is not merely an extension of routine care or a way to ‘enhance’ a business practice. It is its own specialty, requiring extensive medical residency and surgical training that cannot be replaced with optometry school coursework,” Zegans writes.
Lawmakers Target Mental Health Chatbots—Pluribus
Read article—Nicholas Jacobson, an associate professor of biomedical data and psychiatry, is quoted in a story about states’ legislation to regulate therapy chatbots. The story mentions Jacobson’s Therabot study and his recent op-ed and testimony about New Hampshire Senate Bill 640. “These systems need to be designed to mitigate the risks,” Jacobson said. “But at the same time there is a lot of promise here.”
How Stanford Doctors Use AI Scribes to Cut Paperwork and Focus on Patients — Scientific American
Read article – Features a conversation with Christopher Sharp, MED ’98, about how AI is changing medicine and can be used to support patients and doctors. “AI provides an important window to access data locked up in narratives somewhere in the record that would be very hard to identify or find. It also provides the opportunity to utilize data in new ways that does not require as much effort by our clinicians,” Sharp said.
Should Drug Companies Be Advertising to Consumers? — The New York Times
Read article – Steven Woloshin MED ’96, a professor of medicine and community and family medicine, is featured in an article about the debate over direct-to-consumer ads. “Part of aging is developing health conditions and becoming a target of drug advertising,” Woloshin said.